Literature DB >> 31899500

A Class II-Restricted CD8γ13 T-Cell Clone Protects During Chlamydia muridarum Genital Tract Infection.

Raymond M Johnson1, Norma Olivares-Strank1, Gang Peng2.   

Abstract

BACKGROUND: The T-cell response to chlamydia genital tract infections in humans and mice is unusual because the majority of antigen-specific CD8 T cells are not class I restricted (referred to here as "unrestricted" or "atypical"). We previously reported that a subset of unrestricted murine chlamydia-specific CD8 T cells had a cytokine polarization pattern that included interferon (IFN)-γ and interleukin (IL)-13.
METHODS: In this study, we investigated the transcriptome of CD8γ13 T cells, comparing them to Tc1 clones using microarray analysis. That study revealed that CD8γ13 polarization included IL-5 in addition to IFN-γ and IL-13. Adoptive transfer studies were performed with Tc1 clones and a CD8γ13 T-cell clone to determine whether either influenced bacterial clearance or immunopathology during Chlamydia muridarum genital tract infections.
RESULTS: To our surprise, an adoptively transferred CD8γ13 T-cell clone was remarkably proficient at preventing chlamydia immunopathology, whereas the multifunctional Tc1 clone did not enhance clearance or significantly alter immunopathology. Mapping studies with major histocompatibility complex (MHC) class I- and class II-deficient splenocytes showed our previously published chlamydia-specific CD8 T-cell clones are MHC class II restricted.
CONCLUSIONS: The MHC class II-restricted CD8 T cells may play an important role in protection from intracellular pathogens that limit class I antigen presentation or diminish CD4 T-cell numbers or impair their function.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Chlamydiazzm321990 ; CD8; IL-13; IL-5; class II restriction

Mesh:

Substances:

Year:  2020        PMID: 31899500      PMCID: PMC7213565          DOI: 10.1093/infdis/jiz685

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

1.  The arrested immunity hypothesis and the epidemiology of chlamydia control.

Authors:  Robert C Brunham; Michael L Rekart
Journal:  Sex Transm Dis       Date:  2008-01       Impact factor: 2.830

2.  Expression of H-2I region-restricted cytolytic activity by an Lyt-2+ influenza virus-specific T lymphocyte clone.

Authors:  L A Morrison; V L Braciale; T J Braciale
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

3.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

4.  CD8 lymphocytes are sufficient for the development of chronic rejection.

Authors:  Gabriel T Schnickel; David Whiting; George R Hsieh; James J Yun; Michael P Fischbein; Michael C Fishbein; William Yao; Ali Shfizadeh; Abbas Ardehali
Journal:  Transplantation       Date:  2004-12-15       Impact factor: 4.939

5.  Induction and activity of class II-restricted, Lyt-2+ cytolytic T lymphocytes specific for the influenza H5 hemagglutinin.

Authors:  C E Hioe; V S Hinshaw
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

6.  Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells.

Authors:  Luzheng Xue; Shân L Gyles; Frank R Wettey; Lucien Gazi; Elizabeth Townsend; Michael G Hunter; Roy Pettipher
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

7.  CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaques.

Authors:  Norma Olivares-Zavaleta; William M Whitmire; Laszlo Kari; Gail L Sturdevant; Harlan D Caldwell
Journal:  J Immunol       Date:  2014-04-07       Impact factor: 5.422

8.  Discordance in the Epithelial Cell-Dendritic Cell Major Histocompatibility Complex Class II Immunoproteome: Implications for Chlamydia Vaccine Development.

Authors:  Karuna P Karunakaran; Hong Yu; Xiaozhou Jiang; Queenie W T Chan; Leonard J Foster; Raymond M Johnson; Robert C Brunham
Journal:  J Infect Dis       Date:  2020-02-18       Impact factor: 5.226

9.  Chlamydia trachomatis-specific human CD8+ T cells show two patterns of antigen recognition.

Authors:  Malgosia K Matyszak; J S Hill Gaston
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates.

Authors:  Laszlo Kari; William M Whitmire; Norma Olivares-Zavaleta; Morgan M Goheen; Lacey D Taylor; John H Carlson; Gail L Sturdevant; Chunxue Lu; Lauren E Bakios; Linnell B Randall; Michael J Parnell; Guangming Zhong; Harlan D Caldwell
Journal:  J Exp Med       Date:  2011-10-10       Impact factor: 14.307

View more
  4 in total

1.  Combining Cellular Immunology With RNAseq to Identify Novel Chlamydia T-Cell Subset Signatures.

Authors:  Raymond M Johnson; Hiromitsu Asashima; Subhasis Mohanty; Albert C Shaw
Journal:  J Infect Dis       Date:  2022-06-01       Impact factor: 7.759

2.  Th1 cells are dispensable for primary clearance of Chlamydia from the female reproductive tract of mice.

Authors:  Jordan A Rixon; Claire E Depew; Stephen J McSorley
Journal:  PLoS Pathog       Date:  2022-02-23       Impact factor: 6.823

3.  Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?

Authors:  Luis M de la Maza; Toni L Darville; Sukumar Pal
Journal:  Expert Rev Vaccines       Date:  2021-04-28       Impact factor: 5.217

Review 4.  Insights Into Host Cell Cytokines in Chlamydia Infection.

Authors:  Wenjing Xiang; Nanyan Yu; Aihua Lei; Xiaofang Li; Shui Tan; Lijun Huang; Zhou Zhou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.